{"id":12026,"date":"2025-07-03T07:00:00","date_gmt":"2025-07-03T05:00:00","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12026"},"modified":"2026-03-03T10:25:41","modified_gmt":"2026-03-03T09:25:41","slug":"communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/","title":{"rendered":"Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR."},"content":{"rendered":"\n<p class=\"is-style-paragraph-lead-text\"><strong>Interpharma, scienceindustries et Swiss Biotech Association prennent note de la conclusion de l\u2019accord de libre-\u00e9change entre l\u2019AELE dont la Suisse et les \u00c9tats du MERCOSUR. Nous approuvons fondamentalement le libre-\u00e9change en tant que moteur d\u2019accessibilit\u00e9 des march\u00e9s et de prosp\u00e9rit\u00e9. Cependant, pour les entreprises suisses innovantes, un aspect d\u00e9cisif est une protection efficace de la propri\u00e9t\u00e9 intellectuelle. C\u2019est pourquoi les industries innovantes consid\u00e8rent comme indispensable que le gouvernement suisse accompagne \u00e9troitement l\u2019application des normes de protection conform\u00e9ment aux r\u00e8gles de l\u2019accord de l\u2019OMC sur les ADPIC en vigueur.<\/strong><\/p>\n\n\n\n<p>Interpharma, scienceindustries et Swiss Biotech Association saluent le fait que, par l\u2019accord \u00e0 pr\u00e9sent conclu, les \u00c9tats du MERCOSUR reconnaissent clairement les normes de l\u2019accord de l\u2019OMC sur les ADPIC sur la protection de la propri\u00e9t\u00e9 intellectuelle.<\/p>\n\n\n\n<p>Pour les industries suisses innovantes, il est absolument essentiel que la propri\u00e9t\u00e9 intellectuelle soit prot\u00e9g\u00e9e, ind\u00e9pendamment du fait qu\u2019un produit soit import\u00e9 ou de production locale. Pour les entreprises innovantes des secteurs pharmaceutique, chimique et biotechnologique, la protection ad\u00e9quate des donn\u00e9es de tests r\u00e9alis\u00e9s dans le cadre d\u2019\u00e9tudes cliniques en vue de l\u2019autorisation de mise sur le march\u00e9 d\u2019un m\u00e9dicament est \u00e9galement incontournable. Dans ce domaine, nous aurions souhait\u00e9 plus de clart\u00e9 dans le nouvel accord de libre-\u00e9change.<\/p>\n\n\n\n<p>Au sein de l\u2019organe de consultation pr\u00e9vu dans l\u2019accord de libre-\u00e9change, nous comptons \u00e0 pr\u00e9sent sur le gouvernement suisse pour aborder proactivement avec les \u00c9tats du MERCOSUR les \u00e9ventuels d\u00e9fis li\u00e9s \u00e0 l\u2019application des normes de protection ainsi que de futures am\u00e9liorations li\u00e9es \u00e0 l\u2019utilisation et \u00e0 la mise en \u0153uvre de la protection de la propri\u00e9t\u00e9 intellectuelle. La clause de v\u00e9rification convenue fournit au gouvernement suisse l\u2019instrument n\u00e9cessaire \u00e0 cet effet.<\/p>\n\n\n\n<p>Vu la pression internationale et les tensions g\u00e9opolitiques, ainsi que les d\u00e9fis que posent actuellement les march\u00e9s, il est particuli\u00e8rement important d\u2019am\u00e9liorer les conditions cadres pour les industries innovantes, tant par le biais d\u2019accords internationaux solides que par des mesures ad\u00e9quates \u00e0 l\u2019\u00e9chelon national.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2025\/07\/image-2.png\" alt=\"\" class=\"wp-image-27335\"\/><\/figure>\n\n\n\n<p><strong>Contacts<\/strong><\/p>\n\n\n\n<p>Dr Ren\u00e9 Buholzer, Directeur d\u2019Interpharma<br>+41 79 590 98 77<\/p>\n\n\n\n<p>Dr Stephan Mumenthaler, Directeur General Scienceindustries<br>+41 44 368 17 20<\/p>\n\n\n\n<p>Dr Michael Altorfer, CEO Swiss Biotech Association<br>+41 79 636 10 67<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Annexe: importance de la propri\u00e9t\u00e9 intellectuelle pour l\u2019industrie de la recherche<\/strong><\/p>\n\n\n\n<p>Les industries du secteur de la recherche investissent des sommes importantes dans la recherche et le d\u00e9veloppement de produits innovants. Par exemple, le d\u00e9veloppement d\u2019un nouveau m\u00e9dicament co\u00fbte g\u00e9n\u00e9ralement plus de deux milliards de francs. Une fois qu\u2019une innovation a \u00e9t\u00e9 trouv\u00e9e et d\u00e9velopp\u00e9e, il est souvent possible de l\u2019imiter facilement et \u00e0 faible co\u00fbt. D\u2019un point de vue \u00e9conomique, les investissements n\u00e9cessaires ne sont possibles que lorsque la protection de la propri\u00e9t\u00e9 intellectuelle est garantie.<\/p>\n\n\n\n<p>Dans l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC), l\u2019OMC a d\u00e9fini des exigences minimales en mati\u00e8re de protection de la propri\u00e9t\u00e9 intellectuelle que les \u00c9tats membres sont tenus de respecter. Concernant les brevets, les r\u00e8gles suivantes s\u2019appliquent:<\/p>\n\n\n\n<p><strong>TRIPS &#8211; Article 27 (Patentable Subject Matter)<\/strong><\/p>\n\n\n\n<p>\u2026. patents shall be available for any inventions, whether products or processes, in all fields of technology, provided that they are new, involve an inventive step and are capable of industrial application.&nbsp;<\/p>\n\n\n\n<p>\u2026 patents shall be available and patent rights enjoyable without discrimination as to the place of invention, the field of technology and whether products are imported or locally produced.<\/p>\n\n\n\n<p>Les pays de l\u2019OMC ne peuvent donc pas exiger que les produits soient fabriqu\u00e9s \u00e0 l\u2019\u00e9chelle locale pour obtenir une protection efficace par brevet. Une localisation forc\u00e9e est \u00e9galement contraire \u00e0 l\u2019id\u00e9e de libre-\u00e9change, en particulier lorsque les pays sont membres d\u2019un accord de libre-\u00e9change.<\/p>\n\n\n\n<p>Les essais cliniques repr\u00e9sentent une grande partie des co\u00fbts de d\u00e9veloppement de nouveaux m\u00e9dicaments. Les donn\u00e9es ainsi g\u00e9n\u00e9r\u00e9es d\u00e9montrent non seulement l\u2019efficacit\u00e9 et l\u2019am\u00e9lioration par rapport au standard de soins, mais servent \u00e9galement \u00e0 expliquer d\u2019\u00e9ventuels effets secondaires et sont donc essentielles pour la s\u00e9curit\u00e9 des patients et patientes.<\/p>\n\n\n\n<p>Afin de permettre les investissements substantiels dans les essais cliniques, les \u00c9tats membres de l\u2019OMC ont convenu de prot\u00e9ger les donn\u00e9es des essais:<\/p>\n\n\n\n<p><strong>TRIPS &#8211; Article 39 (Protection of Undisclosed Information)<\/strong><\/p>\n\n\n\n<p>Members, when requiring, as a condition of approving the marketing of pharmaceutical or of agricultural chemical products which utilize new chemical entities, the submission of undisclosed test or other data, the origination of which involves a considerable effort, shall protect such data against unfair commercial use. In addition, Members shall protect such data against disclosure, except where necessary to protect the public, or unless steps are taken to ensure that the data are protected against unfair commercial use.<\/p>\n\n\n\n<p>Cet accord garantit que les investissements r\u00e9alis\u00e9s par un innovateur dans les essais cliniques ne peuvent pas \u00eatre simplement utilis\u00e9s pour autoriser des m\u00e9dicaments d\u2019imitation (\u00abme-too\u00bb).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Interpharma, scienceindustries et Swiss Biotech Association prennent note de la conclusion de l\u2019accord de libre-\u00e9change entre l\u2019AELE dont la Suisse et les \u00c9tats du MERCOSUR. Nous approuvons fondamentalement le libre-\u00e9change en tant que moteur d\u2019accessibilit\u00e9 des march\u00e9s et de prosp\u00e9rit\u00e9. Cependant, pour les entreprises suisses innovantes, un aspect d\u00e9cisif est une protection efficace de la [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3558,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[54,120,122],"class_list":["post-12026","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-medien-fr","tag-innovation-fr","tag-communique-de-presse"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR. - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR.\" \/>\n<meta property=\"og:description\" content=\"Interpharma, scienceindustries et Swiss Biotech Association prennent note de la conclusion de l\u2019accord de libre-\u00e9change entre l\u2019AELE dont la Suisse et les \u00c9tats du MERCOSUR. Nous approuvons fondamentalement le libre-\u00e9change en tant que moteur d\u2019accessibilit\u00e9 des march\u00e9s et de prosp\u00e9rit\u00e9. Cependant, pour les entreprises suisses innovantes, un aspect d\u00e9cisif est une protection efficace de la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-03T05:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:25:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/EFTA-Mercosur.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1108\" \/>\n\t<meta property=\"og:image:height\" content=\"692\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR.\",\"datePublished\":\"2025-07-03T05:00:00+00:00\",\"dateModified\":\"2026-03-03T09:25:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/\"},\"wordCount\":891,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/EFTA-Mercosur.jpg\",\"keywords\":[\"M\u00e9dias\",\"Innovation\",\"Communiqu\u00e9 de presse\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/\",\"name\":\"Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR. - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/EFTA-Mercosur.jpg\",\"datePublished\":\"2025-07-03T05:00:00+00:00\",\"dateModified\":\"2026-03-03T09:25:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/EFTA-Mercosur.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/EFTA-Mercosur.jpg\",\"width\":1108,\"height\":692},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR. - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR.","og_description":"Interpharma, scienceindustries et Swiss Biotech Association prennent note de la conclusion de l\u2019accord de libre-\u00e9change entre l\u2019AELE dont la Suisse et les \u00c9tats du MERCOSUR. Nous approuvons fondamentalement le libre-\u00e9change en tant que moteur d\u2019accessibilit\u00e9 des march\u00e9s et de prosp\u00e9rit\u00e9. Cependant, pour les entreprises suisses innovantes, un aspect d\u00e9cisif est une protection efficace de la [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/","og_site_name":"Interpharma","article_published_time":"2025-07-03T05:00:00+00:00","article_modified_time":"2026-03-03T09:25:41+00:00","og_image":[{"width":1108,"height":692,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/EFTA-Mercosur.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR.","datePublished":"2025-07-03T05:00:00+00:00","dateModified":"2026-03-03T09:25:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/"},"wordCount":891,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/EFTA-Mercosur.jpg","keywords":["M\u00e9dias","Innovation","Communiqu\u00e9 de presse"],"inLanguage":"fr-FR","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/","name":"Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR. - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/EFTA-Mercosur.jpg","datePublished":"2025-07-03T05:00:00+00:00","dateModified":"2026-03-03T09:25:41+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/EFTA-Mercosur.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/07\/EFTA-Mercosur.jpg","width":1108,"height":692},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lindustrie-pratiquant-la-recherche-prend-note-de-la-conclusion-de-laccord-de-libre-echange-avec-le-mercosur\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: L\u2019industrie pratiquant la recherche prend note de la conclusion de l\u2019accord de libre-\u00e9change avec le MERCOSUR."}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=12026"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12026\/revisions"}],"predecessor-version":[{"id":12027,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12026\/revisions\/12027"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/3558"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=12026"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=12026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}